QNCX logo

QNCX

Quince Therapeutics, Inc.NASDAQHealthcare
$0.10-3.23%ClosedMarket Cap: $5.5M

As of 2026-04-06

Insider Statistics (Q1 2026)

Purchases

6

Sales

1

Buy/Sell Ratio

6.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Jan 23Thye Dirkdirector, officer: CEO and CMOSell1,000,000$3.081,000,000
Fri Jan 23Ryan Charles S.officer: PresidentSell200,000$3.08200,000
Fri Jan 23Hannah Brendanofficer: CBO, COO & CCOSell365,000$3.08365,000
Wed Jan 21Senner Christopher J.directorSell21,810$3.0021,810
Wed Jan 21McLoughlin MargaretdirectorSell19,547$3.0019,547
Wed Jan 21Lamond DaviddirectorSell29,423$3.0029,423
Wed Jan 21Bray JunedirectorSell18,724$3.0018,724
Mon Dec 29Benatti LucadirectorSell50,000$3.4739,179
Mon Dec 29Benatti LucadirectorSell8,918$0.0089,179
Fri Dec 12Thye Dirkdirector, officer: CEO and CMOSell739,885$0.00739,885